RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Your saved research and appointment questionsView recorded trial and retraction changes
Punctate Inner Choroidopathy: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
A Case of Punctate Inner Choroidopathy in the Fellow Eye Followed by the Development of Solitary Punctate Chorioretinitis With Choroidal Neovascularization
Atsuki Fukushima et al., Cureus (21 September 2026)
https://doi.org/10.7759/cureus.116620
- 2.
Optical Coherence Tomography (OCT) Features of Inactive Multifocal Choroiditis With Panuveitis and Punctate Inner Choroidopathy (MFCPU/PIC) Lesions.
Trinco Andrea et al., American journal of ophthalmology (1 September 2026)
https://pubmed.ncbi.nlm.nih.gov/42191103/
- 3.
Adalimumab Therapy Reduces Treatment Burden in Multifocal Choroiditis/Punctate Inner Choroidopathy.
Ho Benjamin et al., Ocular immunology and inflammation (7 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42567838/
- 4.
Incidence of bilateral disease and choroidal neovascularisation in punctate inner choroiditis.
Liberman Paulina et al., The British journal of ophthalmology (3 July 2026)
https://pubmed.ncbi.nlm.nih.gov/42399072/
- 5.
Punctate Inner Choroidopathy Complicated by Multifocal Neovascularization and Schlaegel Lines.
Chan Hiok Hong et al., Retina (Philadelphia, Pa.) (1 June 2026)
https://pubmed.ncbi.nlm.nih.gov/41202271/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Punctate Inner Choroidopathy
Punctate inner choroidopathy is a rare inflammatory eye condition that causes small spots of inflammation in the choroid and outer retina, usually in young short-sighted women. Symptoms include blurred vision, blind spots and flashes of light. Treatment may involve steroids or other immune-suppressing medicines, and injections are used if abnormal new blood vessels develop.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Punctate Inner Choroidopathy?
Punctate inner choroidopathy is a rare inflammatory eye condition that causes small spots of inflammation in the choroid and outer retina, usually in young short-sighted women. Symptoms include blurred vision, blind spots and flashes of light. Treatment may involve steroids or other immune-suppressing medicines, and injections are used if abnormal new blood vessels develop.
How many clinical trials are available for Punctate Inner Choroidopathy?
RareWays currently indexes 1 clinical trial for Punctate Inner Choroidopathy. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Punctate Inner Choroidopathy come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Punctate Inner Choroidopathy.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.